Company profile

Covidien, LLC

Covidien, LLC has 2 AI-enabled medical devices on the FDA list. The first decision was on May 1, 2026 and the most recent on June 4, 2026 (Instrument Exit Point on Touch Surgery™ Aide). Its most common review panel is Gastroenterology-Urology (1 device).

2AI devices
2026First decision
2026Latest decision
2Specialties

Timeline

  1. Instrument Exit Point on Touch Surgery™ Aide · Gastroenterology-Urology · SFE
  2. Capnostream™35 Portable Respiratory Monitor (PM35MN) · Anesthesiology · CCK